Dual-purpose Vaginal Ring Moves to Clinical Trial

The push to increase women’s ability to protect themselves from simultaneous sexual and reproductive health risks, including unintended pregnancy, HIV, and other sexually transmitted infections, continues with the start of a clinical trial of a three-month vaginal ring. The ring is designed to release dapivirine, an antiretroviral drug to prevent HIV, and levonorgestrel, a contraceptive hormone.